Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01216358 · ClinicalTrials.gov registry record

Boston Migraine and Contraception Study

A clinical trial, sponsored by Planned Parenthood League of Massachusetts.

Completed
Registry status
171
Enrollment target

NCT01216358: Completed study, sponsored by Planned Parenthood League of Massachusetts.

NCT01216358 is a clinical trial that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 171 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01216358 has completed, sponsored by Planned Parenthood League of Massachusetts.

COMPLETED
Registry status
171 participants
Enrollment target

Study Summary

The objectives of this prospective, descriptive study are to: 1. generate estimates of the incidence, prevalence, persistence, clinical impact and attributable risk of migraine due to hormonal contraception (HC) use; and 2. identify predictive factors for clinically significant changes in headache attributable to HC use. The investigators hypothesize that: 1. Most women with pre-existing migraine will have no significant change from baseline headache frequency or clinical impact attributable to HC at 3 months following initiation; a minority will report clinically significant worsening or improvement 2. The incidence of headache and migraine in HC users will not be significantly different from their incidence in NHC users 3. There will be identifiable risk factors for development or worsening of headache/migraine in the minority of HC users where that occurs.

Primary Outcome

Our primary outcome is the change in the proportion of headache days over 84 days, adjusted for baseline headache frequency

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2010-10
Est. Completion 2011-12

What the finished NCT01216358 record still lists

NCT01216358 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01216358 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01216358 about?

NCT01216358 is a clinical study titled "Boston Migraine and Contraception Study". The objectives of this prospective, descriptive study are to: 1. generate estimates of the incidence, prevalence, persistence, clinical impact and attributable risk of migraine due to hormonal contraception (HC) use; and 2. identify predictive factors for clinically significant changes in headache ...

What is the current status of trial NCT01216358?

This trial is currently completed. The enrollment target is 171 participants. The study started on 2010-10. Estimated completion is 2011-12.

Who is sponsoring clinical trial NCT01216358?

This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01216358, the US trial registry maintained by the National Library of Medicine. NCT01216358 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.